Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study. (21st October 2017)
- Record Type:
- Journal Article
- Title:
- Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study. (21st October 2017)
- Main Title:
- Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study
- Authors:
- Zhao, Yan
Wu, Zunyou
McGoogan, Jennifer M
Shi, Cynthia X
Li, Aihua
Dou, Zhihui
Ma, Ye
Qin, Qianqian
Brookmeyer, Ron
Detels, Roger
Montaner, Julio S G - Abstract:
- Abstract : We enrolled 34581 individuals newly diagnosed with human immunodeficiency virus infection with CD4 cell counts >500 cells/μL and found that initiation of antiretroviral therapy within 30 days of diagnosis was associated with a 63% reduction in overall mortality at 12 months of follow-up. Abstract: Background: Clinical trials have demonstrated that immediate initiation of antiretroviral therapy (ART) reduces AIDS-related morbidity and mortality. We tested the hypothesis that initiating ART ≤30 days after human immunodeficiency virus (HIV) diagnosis would be associated with reduced mortality among people living with HIV (PLWH) with CD4 counts >500 cells/μL. Methods: PLWH enrolled in the Chinese National HIV Information System between January 2012 and June 2014 with CD4 counts >500 cells/μL were followed for 12 months. Cox proportional hazards model was used to determine hazard ratios (HRs) for PLWH who initiated ART after HIV diagnosis. ART initiation was treated as a time-dependent variable. Results: We enrolled 34581 PLWH with CD4 >500 cells/μL; 1838 (5.3%) initiated ART ≤30 days after diagnosis (immediate ART group), and 19 deaths were observed with a mortality rate of 1.04 per 100 person-years (PY). Fifty-eight deaths were documented among the 5640 PLWH in the delayed ART group with a mortality rate of 2.25 per 100 PY. There were 713 deaths among the 27103 PLWH in the no ART group with a mortality rate of 2.39 per 100 PY. After controlling for potentialAbstract : We enrolled 34581 individuals newly diagnosed with human immunodeficiency virus infection with CD4 cell counts >500 cells/μL and found that initiation of antiretroviral therapy within 30 days of diagnosis was associated with a 63% reduction in overall mortality at 12 months of follow-up. Abstract: Background: Clinical trials have demonstrated that immediate initiation of antiretroviral therapy (ART) reduces AIDS-related morbidity and mortality. We tested the hypothesis that initiating ART ≤30 days after human immunodeficiency virus (HIV) diagnosis would be associated with reduced mortality among people living with HIV (PLWH) with CD4 counts >500 cells/μL. Methods: PLWH enrolled in the Chinese National HIV Information System between January 2012 and June 2014 with CD4 counts >500 cells/μL were followed for 12 months. Cox proportional hazards model was used to determine hazard ratios (HRs) for PLWH who initiated ART after HIV diagnosis. ART initiation was treated as a time-dependent variable. Results: We enrolled 34581 PLWH with CD4 >500 cells/μL; 1838 (5.3%) initiated ART ≤30 days after diagnosis (immediate ART group), and 19 deaths were observed with a mortality rate of 1.04 per 100 person-years (PY). Fifty-eight deaths were documented among the 5640 PLWH in the delayed ART group with a mortality rate of 2.25 per 100 PY. There were 713 deaths among the 27103 PLWH in the no ART group with a mortality rate of 2.39 per 100 PY. After controlling for potential confounding factors, ART initiation at ≤30 days (adjusted HR, 0.37 [95% confidence interval, .23–.58]) was a statistically significant protective factor. Conclusions: We found that immediate ART is associated with a 63% reduction in overall mortality among PLWH with CD4 counts >500 cells/μL in China, supporting the recommendation to initiate ART immediately following HIV diagnosis. … (more)
- Is Part Of:
- Clinical infectious diseases. Volume 66:Number 5(2018)
- Journal:
- Clinical infectious diseases
- Issue:
- Volume 66:Number 5(2018)
- Issue Display:
- Volume 66, Issue 5 (2018)
- Year:
- 2018
- Volume:
- 66
- Issue:
- 5
- Issue Sort Value:
- 2018-0066-0005-0000
- Page Start:
- 727
- Page End:
- 734
- Publication Date:
- 2017-10-21
- Subjects:
- HIV/AIDS -- antiretroviral therapy -- treatment initiation -- CD4 count -- mortality
Communicable diseases -- Periodicals
616.905 - Journal URLs:
- http://cid.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://www.journals.uchicago.edu/CID/journal ↗
http://www.jstor.org/journals/10584838.html ↗ - DOI:
- 10.1093/cid/cix878 ↗
- Languages:
- English
- ISSNs:
- 1058-4838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.293860
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17055.xml